Abits
ABTS
Intchains Group
ICG
The9 Ltd
NCTY
CATHEDRA BITCOIN INC
CBTTF
Canaan
CAN
US Stock MarketDetailed Quotes
INCY Incyte
- 68.583
- -0.647-0.93%
Trading Dec 30 13:38 ET
13.21BMarket Cap762.04P/E (TTM)
68.870High67.700Low334.29KVolume68.560Open69.230Pre Close22.82MTurnover0.21%Turnover Ratio25.88P/E (Static)192.65MShares83.95052wk High4.17P/B11.01BFloat Cap50.35052wk Low--Dividend TTM160.50MShs Float153.150Historical High--Div YieldTTM1.69%Amplitude1.850Historical Low68.273Avg Price1Lot Size
About Incyte Company
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded in April 1991 and is headquartered in Wilmington, DE.
Company Profile
SymbolINCY
Company NameIncyte
Listing DateNov 4, 1993
Issue Price7.50
Founded1991
CEOMr. Herve Hoppenot
MarketNASDAQ
Employees2524
Fiscal Year Ends12-31
Address1801 Augustine Cut-Off
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19803
Phone1-302-498-6700
Websitehttp://www.incyte.com
Company Executives
- Name
- Position
- Salary
- Herve Hoppenot
- Chairman of the Board, President and Chief Executive Officer
- 16.66M
- Dr. Steven H. Stein, M.D.
- Executive Vice President and Chief Medical Officer
- 5.63M
- Thomas Tray
- Vice President and Chief Accounting Officer
- --
- Christiana Stamoulis, M.B.A.
- Executive Vice President and Chief Financial Officer
- 5.08M
- Barry P. Flannelly, Pharm.D.
- Executive Vice President and General Manager, North America
- 4.09M
- Jonathan Elliott Dickinson
- Executive Vice President and General Manager, Europe
- --
- Vijay K. Iyengar
- Executive Vice President, Global Strategy and Corporate Development
- --
- Michael James Morrissey
- Executive Vice President and Head of Global Technical Operations
- --
- Paula J. Swain
- Executive Vice President, Human Resources
- --
- Sheila A Denton
- Executive Vice President, General Counsel and Corporate Secretary
- --
- Dr. Pablo J. Cagnoni, M.D.
- President and Head of Research and Development
- 15.83M
- Paul J. Clancy
- Independent Director
- 479.76K
- Dr. Susanne Schaffert, PhD
- Independent Director
- 444.76K
- Julian C. Baker
- Lead Independent Director
- 512.76K
- Dr. Otis W. Brawley,M.D.
- Independent Director
- 454.76K
- Dr. Edmund P. Harrigan, M.D.
- Independent Director
- 482.26K
- Dr. Katherine A. High, M.D.
- Independent Director
- 454.76K
- Jean-Jacques Bienaime
- Independent Director
- 478.76K
- Dr. Jacqualyn A. Fouse, PhD
- Independent Director
- 466.26K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
